Kinneret Livnat-Savitsky
Director/Board Member bij COMPUGEN LTD.
Profiel
Kinneret Livnat-Savitsky is currently the Chairman at ImmPACT-Bio Ltd.
and serves as an Independent Director at Compugen Ltd., Director at Ramot at Tel Aviv University Ltd., Director at DreaMed Diabetes Ltd., and Director at Biomica Ltd.
Previously, she held the position of Chief Executive Officer at BioLineRx Ltd.
from 2012 to 2016 and at FutuRx Ltd.
from 2017 to 2021.
She also served as Chairman at KAHR Medical Ltd., Director at Hadasit Medical Research Services & Development Ltd., Director at Evogene Ltd.
from 2010 to 2013, Independent Non-Executive Director at Nutritional Growth Solutions Ltd., and General Manager at BioJerusalem.
Additionally, she was the General Manager at Bioline Innovations Jerusalem LP from 2004 to 2010.
Dr. Livnat-Savitsky obtained a graduate and doctorate degree from Tel-Aviv University in 1997 and an undergraduate degree from The Hebrew University of Jerusalem in 1990.
Actieve functies van Kinneret Livnat-Savitsky
Bedrijven | Functie | Begin |
---|---|---|
COMPUGEN LTD. | Director/Board Member | 11-06-2018 |
ImmPACT-Bio Ltd.
ImmPACT-Bio Ltd. BiotechnologyHealth Technology ImmPACT-Bio Ltd. develops therapies to treat cancer. Its chimeric antigen receptor T-cell (CAR-T) therapy addresses the need to differentiate cancerous from non-cancerous tissues. The company was founded by Gideon Gross in April 2017 and is headquartered in Nes Ziona, Israel. | Chairman | - |
Dreamed Diabetes Ltd.
Dreamed Diabetes Ltd. Packaged SoftwareTechnology Services DreaMed Diabetes Ltd. is a medical technology company based in Petach Tikva, Israel. DreaMed Diabetes is currently commercializing its endo.digital AI-based clinical decision support system for diabetes management. The endo.digital platform has FDA clearance for patients with type 1 diabetes using continuous glucose monitors or self-monitoring blood glucose monitor devices and insulin pumps. The technology also received expanded FDA clearance to include patients with type 1 or type 2 diabetes on multiple daily injections. The Israeli company's first product, an artificial pancreas technology, was licensed to Medtronic and incorporated into its 780g insulin pump technology. The company provides personalized diabetes treatment optimization solutions and was founded in 2014 by Revital Nimri, Tadej Battelino, Eran Atlas, Thomas Danne, and Ido Muller. Eran Atlas has been the CEO since 2014. | Director/Board Member | - |
Biomica Ltd.
Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Director/Board Member | - |
Ramot at Tel Aviv University Ltd.
Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel. | Director/Board Member | - |
Eerdere bekende functies van Kinneret Livnat-Savitsky
Bedrijven | Functie | Einde |
---|---|---|
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Chief Executive Officer | 02-01-2021 |
BIOLINERX LTD. | Chief Executive Officer | 10-10-2016 |
Bioline Innovations Jerusalem LP | Corporate Officer/Principal | 01-01-2010 |
Hadasit Medical Research Services & Development Ltd.
Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Director/Board Member | - |
░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Opleiding van Kinneret Livnat-Savitsky
Tel-Aviv University | Doctorate Degree |
The Hebrew University of Jerusalem | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
COMPUGEN LTD. | Health Technology |
BIOLINERX LTD. | Health Technology |
EVOGENE LTD. | Health Technology |
NUTRITIONAL GROWTH SOLUTIONS LTD. | Health Technology |
Bedrijven in privébezit | 9 |
---|---|
Ramot at Tel Aviv University Ltd.
Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel. | Commercial Services |
Hadasit Medical Research Services & Development Ltd.
Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Commercial Services |
BioJerusalem
BioJerusalem Financial ConglomeratesFinance BioJerusalem engages in the provision of financial assistance to life sciences companies choosing to launch operations in Jerusalem, which are eligible for prime financial support incentives and are given special preference. The company is headquartered in Jerusalem, Israel. | Finance |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Finance |
ImmPACT-Bio Ltd.
ImmPACT-Bio Ltd. BiotechnologyHealth Technology ImmPACT-Bio Ltd. develops therapies to treat cancer. Its chimeric antigen receptor T-cell (CAR-T) therapy addresses the need to differentiate cancerous from non-cancerous tissues. The company was founded by Gideon Gross in April 2017 and is headquartered in Nes Ziona, Israel. | Health Technology |
Dreamed Diabetes Ltd.
Dreamed Diabetes Ltd. Packaged SoftwareTechnology Services DreaMed Diabetes Ltd. is a medical technology company based in Petach Tikva, Israel. DreaMed Diabetes is currently commercializing its endo.digital AI-based clinical decision support system for diabetes management. The endo.digital platform has FDA clearance for patients with type 1 diabetes using continuous glucose monitors or self-monitoring blood glucose monitor devices and insulin pumps. The technology also received expanded FDA clearance to include patients with type 1 or type 2 diabetes on multiple daily injections. The Israeli company's first product, an artificial pancreas technology, was licensed to Medtronic and incorporated into its 780g insulin pump technology. The company provides personalized diabetes treatment optimization solutions and was founded in 2014 by Revital Nimri, Tadej Battelino, Eran Atlas, Thomas Danne, and Ido Muller. Eran Atlas has been the CEO since 2014. | Technology Services |
Biomica Ltd.
Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Commercial Services |
Bioline Innovations Jerusalem LP |